Enterotoxigenic Escherichia coli strains produce heat-labile and heat-stable enterotoxins that cause intestinal fluid secretion and diarrhea in animals and humans. The heat-labile enterotoxins (LTI and LTII) are oligomeric proteins possessing structural and functional similarities to cholera toxin. By contrast, the heat-stable enterotoxins (STa and STb) are peptides containing multiple disulfide bonds. STa is an 18-or 19-aminoacid acidic peptide with three intramolecular disulfide bonds. STa acts by binding to a high-affinity, specific protein receptor (guanylyl cyclase C) located in the brush border membrane of intestinal epithelial cells, and the molecular mechanism by which STa elicits intestinal fluid secretion is known in detail (16, 35, 42) . Unlike the case for STa, the steps that lead to intestinal fluid secretion by STb are not well established. STb is a 48-amino-acid basic peptide composed of two ␣ helices stabilized by a couple of disulfide bonds (6, 7, 14) . The amphipathic N-terminal (residues 10 to 22) and hydrophobic C-terminal (residues 38 to 44) helices are connected by a 16-amino-acid flexible loop which contains a cluster of hydrophobic residues (46). The two disulfide bonds are critical for the biological activity of STb, as are the polar residues (Arg29 and Asp30) of the flexible loop (2, 6, 7, 46) . In vitro experiments indicate that following the initial binding of STb to cells through an uncharacterized process, STb activates a pertussis toxin-sensitive G protein (G i3 ) in several different cell lines of intestinal and nonintestinal origin, resulting in calcium ion entry through an apparent ligand-gated calcium ion channel (5, 20, 21) . This elevated intracellular Ca 2ϩ concentration has been implicated in possible stimulation of arachidonic acid release from membrane phospholipids, possibly through phospholipase C activity (13). In vivo, STb treatment results in a dose-dependent rise in the level of arachidonic acid and subsequent formation of prostaglandin E 2 , an intestinal secretagog (13, 20, 37, 38) . STb action also mediates the dose-dependent release of another intestinal segretagog, 5-hydroxytryptamine (5-HT), presumably from intestinal enterochromaffin cells, implicating involvement of the enteric nervous system in the signal transduction process mediated by STb (20, 23, 24) . In vitro studies using rat basophilic leukemia (RBL-2H3) cells as a model for 5-HT release indicate that G-protein activation is involved in the STb-mediated release of 5-HT (21). The in
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In this study we systematically examined the binding of E. coli STb to two colonic carcinoma cells, T84 and HT29, and polarized T84 cells (i) to characterize the initial step in toxin action prior to the induction of the above-noted signaling mechanisms and (ii) to identify an STb-specific cell surface receptor. Our results indicate that STb binds to the intestinal epithelial cells in general through low-affinity cell surface receptors that lead to plasma membrane association and internalization of STb into the cytoplasm. The processes by which STb membrane association may mediate fluid secretion in the small intestine through G-protein activation are discussed.
MATERIALS AND METHODS
Preparation of STb. E. coli STb was purified as described by Harville and Dreyfus (20) . Purity of toxin preparations was routinely verified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on 12.5% acrylamide gels containing 6% bisacrylamide and the Tris-Tricine buffering system of Schägger and von Jagow (41) . Biological activity of STb was assessed by the ligated intestinal loop assay (51) .
Radiolabeling of STb. STb (10 g) in 20 l of 0.2 M sodium phosphate (pH 7.1) was incubated with 0.5 to 1 mCi of Na 125 I (NEN-Dupont, Boston, Mass.) at 22°C in a glass tube coated with 1 g of Iodo-Gen (Pierce, Rockford, Ill.). After 5 min, the reaction was terminated by transferring the mixture to a new glass tube. The first tube was then rinsed with 0.4 ml of 10 mM ammonium acetate (pH 5.8), and the combined reaction mixture was incubated for an additional 15 min. Free 125 I was removed by filtering the 125 I-STb sample through a C 8 reversephase chromatography cartridge (SepPak cartridge; Waters, Milford, Mass.). 125 I-STb was eluted from the cartridge with 80% (vol/vol) acetonitrile after the cartridge was washed with water and then with 20% (vol/vol) acetonitrile. Acetonitrile solutions contained 0.05% (vol/vol) trifluoroacetic acid.
125 I-labeled toxin was dried in a vacuum concentrator before being dissolved in phosphatebuffered saline (PBS; pH 7.4)-3 mg of bovine serum albumin (BSA) per ml to a final concentration of ϳ10 M. 6 cells/ml and allowed to grow to confluency in DMEM-10% FBS. The transepithelial electrical resistance of differentiated T84 cells was measured with a Milicell-ERS resistance monitor (Millipore Corp., Bedford, Mass.). The transepithelial resistance of polarized T84 cells used in the binding experiments ranged from ϳ350 to 1,100 ⍀/cm 2 . In preliminary experiments, T84 cells grown in this manner were examined by phase-contrast and transmission electron microscopy for the presence of brush border membranes as evidence for polarization. Brush border membranes could be detected by phase-contrast microscopy and clearly seen by transmission electron microscopy (47a). During this study, T84 cells grown on membrane inserts were routinely examined by phase-contrast microscopy to confirm that high transepithelial resistance was coincident with the appearance of brush border membranes. For equilibrium binding experiments, T84 and HT29 cells were seeded in 24-well plates (Falcon), and binding experiments were conducted when the cells reached ϳ80 to 95% confluency (2 ϫ 10 5 to 3 ϫ 10 5 cells) in ϳ3 to 4 days. After the cell monolayers were washed three times with PBS and twice with PBS-0.1% (wt/vol) BSA, 125 I-STb (0.05 to 7.0 M) was added to the cells, which were then incubated for the indicated times and at various temperatures. For the polarized T84 cells, 1 ml and 0.15 to 0.5 ml of DMEM were added to the lower and upper compartments, respectively, when 125 I-STb binding to the apical and basolateral surfaces was examined. Unbound 125 I-STb was removed by aspiration, and the cells were washed three times with 2 ml of ice-cold PBS.
125 I-STb bound to T84 and HT29 cells was determined by solubilizing the cells with 1 N NaOH for 1 h at 37°C. 125 (18, 29, 43, 45) . The cell surface-bound 125 I-STb, released by acetic acid treatment, was removed after 10 min of incubation at 4°C.
125 I-STb which remained associated with the cells was released and quantified as described above. Exposure to the acidic saline solution had no observable adverse effect on cellular integrity in that Ͼ95% of the undifferentiated and polarized T84 cells excluded trypan blue following the treatment.
Effects of cell surface molecules and cellular perturbants on STb binding and internalization. For binding inhibition studies, cultured intestinal cells were incubated with 10 g of cytochalasin D (Sigma, St. Louis, Mo.) per ml, 0.45 M sucrose, or 5 mM sodium azide in PBS for 20 min at 37°C before the addition of 125 I-STb. Binding and internalization studies were then performed as described above. The role of cell surface sialic acid in STb binding was tested by treating cells with 0.1 U of Vibrio cholerae neuraminidase (Calbiochem-Novobiochem, San Diego, Calif.) per ml for 2 h at 37°C in 50 mM sodium acetate (pH 5.5) or DMEM in the presence of 1 mM CaCl 2 (30) . After neuraminidase treatment, the cells were washed twice with PBS before the addition of 125 I-STb. The cells were also treated with 1 U of Flavobacterium meningosepticum endoglycosidase F/peptide N-glycosidase F (endo F/PNGase F; Boehringer Mannheim, Indianapolis, Ind.) per ml for 5 h at 37°C in DMEM (10) . For tunicamycin treatment, the cells were incubated with 10 g of tunicamycin (Sigma) per ml in complete medium for 16 h at 37°C to inhibit asparagine-linked glycosylation of cell surface proteins (10, 28) . Tunicamycin concentrations greater than 10 g/ml were toxic to both T84 and HT29 cells. Viability of the cells after tunicamycin treatment was determined with visual inspection by phase-contrast microscopy as well as by testing their ability to exclude trypan blue. To determine any role that sulfated glycosaminoglycans may play in the interaction between STb and the intestinal epithelial cells, T84 and HT29 cells grown in complete medium containing 5 mM sodium chlorate for 3 days at 37°C, a condition that inhibits proteoglycan sulfation, were subsequently used in the toxin binding assay (3, 4, 17, 25, 27) . The role of surface proteins in STb binding was assessed by incubating the cells with 0.05 to 0.2 mg of trypsin (Mediatech) per ml for 30 min at 37°C in PBS. Trypsin proteolysis was terminated by the addition of FBS to the reaction mixture to a final concentration of 10% (vol/vol). The cells were then washed twice with 0.2 ml of soybean trypsin inhibitor (0.5 mg/ml; Sigma) in PBS and three times with 1 ml of PBS-0.1% BSA, prior to 125 I-STb binding since the biological activity of STb is highly sensitive to trypsin-like protease in the gut of animals (51). These washes were sufficient to inactivate trypsin, since both the unbound 125 I-STb in the sample and the cell surface bound 125 I-STb were precipitable by TCA to the same extent as the control 125 I-STb, which did not come in contact with trypsin. Trypsin proteolysis resulted in STb fragments which were not efficiently precipitated with TCA (4a, 6). Binding experiments were performed at least three times with triplicate samples. Each figure represents a typical experiment, with data points indicating the mean Ϯ standard deviation of triplicate determinations.
Immunocytochemistry of STb binding to T84 and HT29 cells. Indirect immunofluorescence analysis was performed to visualize STb bound to the T84 and HT29 cells (19) . Anti-STb antibody was obtained by immunizing New Zealand White female rabbit with purified STb covalently coupled to itself by disuccinimidyl suberate (DSS; Pierce) treatment. A standard course of immunizations was followed (47a), and the immunoglobulin G (IgG) fractions from the preimmune and high-titer anti-STb antibody-containing sera were prepared by protein A-Sepharose fast protein liquid chromatography. For indirect immunofluorescence, STb (0.5 to 6 M) was incubated for 30 min at 37°C with T84 or HT29 cells grown on circular glass coverslips (Fisher) in 24-well tissue culture plates. Cells were washed before and after STb binding as described for the equilibrium binding assay. STb-bound cells were fixed by incubation for 15 min with freshly prepared 4% (wt/vol) paraformaldehyde (Sigma) and were permeabilized by being treated twice with PBS-0.2% (vol/vol) Triton X-100 (Sigma). The cells were then incubated with a 1:25 dilution of anti-STb antibody or preimmune serum in PBS-3% (wt/vol) BSA for 1 h at 22°C. The STb-bound cells were then incubated with a 1:100 dilution of goat anti-rabbit IgG-rhodamine conjugate (Calbiochem-Novobiochem) in PBS-3% BSA for 30 min. After being washed, STb-bound cells were visualized and photographed with a camera-equipped, incident fluorescence (Olympus BX50) microscope. Samples were illuminated with a 100-W mercury lamp, using a 20-nm bandpass excitation filter centered at 552 nm and a 570-nm emission filter. I-STb to T84 cells was reduced by ϳ50% in the presence of 5-fold excess unlabeled STb, but the binding did not decrease further in the presence of 100-to 1,000-fold excess STb (Fig. 1A) , indicating that unlabeled STb could specifically compete with Fig. 2A and B) . The amount of surface-bound 125 I-STb on HT29 cells was slightly higher than that on T84 cells (ϳ65% Ϯ 12%). For both cell types, the fraction of surface-bound Table 1 ), indicating that sialic acid residues were not involved in STb binding to its receptor.
RESULTS

Binding
Glycosaminoglycans are the negatively charged polysaccharide components of extracellular matrix-associated proteoglycans. Disaccharide units contain various amounts of sulfate groups on the carbohydrate backbone and extensive sulfation of glycosaminoglycans results in a polyanionic cell surface structure (24) . In cultured cells, chlorate prevents the formation of adenosine 3Ј-phosphate-5Ј-phosphosulfate, thus leading to a reduction in N-sulfation, and results in a stoichiometric increase in unmodified chondroitin sulfate (N-acetylgalactosamine) and heparan sulfate (N-acetylglucosamine) residues (3, 4, 17, 25, 27 Immunocytochemistry of STb-bound cells. Indirect immunofluorescence was used to assess the fate of cell-bound STb. Following binding to T84 and HT29 cells, the resulting fluorescence was primarily concentrated at the plasma membrane of both intestinal epithelial cell types (Fig. 3C to F) . Toxintreated cells, subsequently washed with acidic saline solution to remove surface-bound STb, displayed a significant fluorescence signal at the periphery of T84 (Fig. 3D ) and HT29 cells (Fig. 3F) ; however, the fluorescence intensities were lower than those for untreated cells (Fig. 3C and E) . Although diffuse cytoplasmic staining was observed in toxin-treated cells, staining of vesicles or cellular organelles was negligible ( Fig.  3D and F) . It should be noted that in this experiment the fluorescence signal at the plasma membrane is possibly accentuated by varied thickness of the cells. In control experiments, STb-bound cells incubated with goat anti-rabbit IgG-rhodamine conjugate alone (no primary antibody) failed to yield a fluorescent signal (not shown). STb-bound cells incubated with preimmune IgG as the primary antibody yielded a weak fluorescent signal (Fig. 3A) . This background fluorescence observed with preimmune IgG (Fig. 3A) was reduced by acid treatment, indicating the presence of low-level cross-reactive anti-STb antibodies in this IgG fraction (Fig. 3B) . We also examined STb binding to Chinese hamster ovary (CHO) and mouse 3T3 fibroblast cells by indirect immunofluorescence to determine if STb binding and internalization were cell-type specific events. STb bound to CHO and mouse 3T3 fibroblast cells with low affinity, as detected by weak (above background) fluorescence signals (not shown), while the T84 and HT29 cells always fluoresced uniformly (Fig. 3C to F) . In addition, the intensities of immunostained CHO and mouse 3T3 fibroblast cells varied significantly within and between experiments compared to T84 and HT29 cells.
The amounts of I-STb bound was found to associate with the cell membrane fraction at 37°C (20.1% Ϯ 7.8%) and at 4°C (23.7% Ϯ 6.5%). The majority of the cytosolic 125 I-STb of both untreated and acidtreated cells was an intact toxin, since ϳ65% Ϯ 10% of radiolabel in the supernatant following cell fractionation could be precipitated with 10% TCA. Although immunofluorescence analysis of STb-bound cells suggested that the toxin was predominantly plasma membrane associated, subcellular fractionation results indicated that a greater fraction of cell-bound 125 I-STb was in the soluble cytoplasmic fraction. However, it was not possible to account for the amount of membranebound 125 I-STb that may be dislodged from the membrane fraction during the homogenization process.
Effects of inhibitors on the internalization of 125 I-STb. The association of STb with the cell plasma membrane and subsequent internalization of toxin into the cytoplasm could occur through several endocytic pathways involving clathrin-coated pits, coated vesicles, and caveolae (or plasma laminal vesicles).
We tested the effect of cytoskeleton-disrupting agents, which inhibit endocytic processes, on 125 I-STb binding and internalization by T84 cells. Pretreatment of T84 cells with cytochalasin D (10 g/ml) or HT29 cells with colchicine (40 g/ml) did not significantly lower the extent of STb binding to these cell types (Table 1 ). These data indicated that actin filaments and microtubules were not involved in the membrane association or subsequent internalization of STb. To determine if STb internalization occurs through an energy-dependent process, T84 and HT29 cells were metabolically blocked by treatment with 5 mM sodium azide and then assessed for toxin internalization. Azide treatment had no effect on the equilibrium binding or internalization of 125 I-STb to the intestinal epithelial cells (Table 1) . Finally, abrogation of endocytosis by treatment of the cells with 0.45 M sucrose to induce a hypertonic condition (39) did not greatly affect the fate of surface-bound STb (Table 1) . Although the total 125 I-STb bound to T84 cells decreased by ϳ30% in sucrose containing buffer, the ratio of surface bound to the internalized 125 I-STb was the same for sucrose-treated and control cells ( Table 1) .
Binding of STb to polarized T84 cells. Our experimental results with undifferentiated T84 and HT29 cells under various experimental conditions strongly indicated that STb is binding to a nonproteinaceous receptor(s) on the cell surface with low affinity. It is likely that STb bound to these same receptors is responsible for the influx of Ca 2ϩ into Madin-Darby canine kidney epithelial, human HT29 intestinal epithelial, and rat primary pituitary cells (5) and the release of 5-HT in rat basophilic leukemic (RBL-2H3) cells (21) . However, in vivo, STb initially comes in contact with the apical surface of the polarized intestinal epithelial cells in the lumen. It is possible that an STb-specific receptor exists exclusively on the apical surface of polarized intestinal epithelial cells but not on the surface of undifferentiated intestinal epithelial cells. We used polarized T84 cells to determine if the apical surface contains a specific receptor for STb. Results for equilibrium binding of 125 I-STb (7.5 to 90 pmol), applied apically, in the presence (nonspecific) and absence (total) of 100-fold STb to polarized T84 cells are shown in Fig. 4 . Unlike STb binding to undifferentiated T84 and HT29 cells (Fig. 1B) , the total and nonspecific binding isotherms for STb-polarized T84 cells overlapped, indicating that the apical surface of polarized T84 cells did not have a high-affinity, specific receptor for STb. We then asked whether STb bound to polarized T84 cells is stably associated with the cells. We found that ϳ80% Ϯ 10% of cell-bound STb was removable by treatment with acidic saline solution (Fig. 5) . This value for polarized T84 cells (ϳ80% Ϯ 10%) is higher than those for T84 cells (55% Ϯ 10%) and HT29 cells (ϳ65% Ϯ 12%). However, the percentage of surface-bound 125 I-STb was the same within experimental errors for samples containing excess STb and for samples in which the toxin was applied basolaterally (not shown). We also observed that the percent of surface-bound 125 I-STb did not vary as a function of transepithelial resistance of polarized T84 cells (Fig. 5) .
DISCUSSION
Like most extracellular molecules that elicit specific cell and tissue responses, the E. coli heat-stable enterotoxin STb must initially interact at the surface of target cells. Due to the lack of information on the interaction of STb with columnar epithelial cells of the mammalian small intestine, we investigated the interaction of STb with cultured intestinal epithelial cells and polarized T84 cells by using a combination of I-STb and 70 nmol of STb) that far exceed the dose of STb (ϳ100 pmol) required for cellular signaling and intestinal secretion (6, 14, 20) . Subsequent removal of sialic acid and N-linked sugar residues from surface-exposed glycoproteins, inhibition of N-linked glycosylation by tunicamycin treatment, prevention of glycosaminoglycan sulfation, and trypsin digestion of surface proteins all failed to reduce STb binding to T84 and HT29 cells. We then examined the STb binding to polarized T84 cells to see if we could identify an STb-specific receptor on the apical surface of intestinal epithelial cell, since the distribution of proteins and lipids differs for the apical and basolateral membranes, and the protein and lipid compositions of basolateral membrane of polarized epithelial cells resemble those of the plasma membrane of undifferentiated cells (44) . The results for polarized T84 cells are in agreement with those for STb binding to undifferentiated intestinal epithelial cells. That is, the apical surface of polarized T84 cells did not contain a specific receptor for STb, and ϳ20% Ϯ 10% of bound STb is stably associated with the cells when applied basolaterally or apically. The lack of some proteins and lipids on the basolateral surface of polarized T84 cells did not appear to inhibit the amount of stably bound STb. Together, these data suggest that STb binds to cultured intestinal epithelial cells (both undifferentiated and polarized) in manner probably involving interaction with membrane lipids or membrane bilayer, instead of a specific protein receptor. However, STb appears to have selectivity in interaction with plasma membranes, since STb binds with lower affinity to CHO cells and fibroblasts than to intestinal epithelial cells.
A somewhat unexpected finding was that once STb was cell bound, nearly one-quarter and one-half of the STb became stably integrated into the plasma membrane of polarized and undifferentiated intestinal epithelial cells, respectively. Our conclusion is based on standard methods used to assess ligand distribution following specific receptor binding events. After normal ligand-receptor interactions, the bound ligand could either remain on the cell surface or enter the cells through a receptor-mediated endocytosis involving clathrin-coated or uncoated pits or vesicles. When formed at 4°C, typical ligandreceptor complexes remain on the cell surface as long as cells are maintained at a low temperature, and all bound ligand on the cell surface can be removed by treatment of the cells with acidic saline solutions (18, 29, 40, 45) . Acid-resistant ligand represents the fraction which was stably associated with the membrane and/or endocytosed by the cell. Typically, warming the ligand-bound cells from 4 to 37°C results in a time-and temperature-dependent increase in acid-resistant 125 I-STb as the ligand becomes internalized by the cell. As reported here, STb was internalized by cultured intestinal epithelial cells by a process which was independent of temperature, cytoskeleton rearrangements, energy, or hypertonic conditions. This observation suggests that processes such as clathrin-dependent and clathrin-independent endocytosis, internalization of caveolae, or micropinocytosis are not involved in the apparent membrane association or internalization of STb (36) . Further, the association of 10 to 140 kDa, the same proteins were cross-linked to 125 I-STb in the presence of 1,000-fold unlabeled toxin (not shown). It is unclear whether the 25-kDa protein is located at the cell surface, embedded in the membrane, or free in the cytoplasmic fraction, but it may represent a protein to which STb binds following membrane association and internalization. Based on the experimental data presented in this report, we suggest that the 25-kDa protein does not represent a surface-exposed specific receptor for STb but rather may represent either a cytoplasmic protein or a protein associated with the inner leaflet of the plasma membrane to which STb binds.
The structure of STb, antiparallel ␣ helices joined by disulfide bonds, has been identified in only two other proteins and in a group of related peptides (thionins) (46) . Thionins from various plant species are of special interest to us since these amphipathic, cysteine-rich (three to four disulfide bonds), basic (ϳ5,000 Da with high concentrations of lysine and arginine residues) peptides also induce cellular uptake of Ca 2ϩ , cause K ϩ efflux, release arachidonic acid, and activate phospholipase A 2 (8, 26, 33, 34, 47) . As for STb, the initial binding of thionins to mammalian erythrocytes and phospholipid vesicles proceeds through an electrostatistic interaction of the positively charged thionins and negatively charged cell membrane (33, 34, 48, 49) to exert hemolytic, neurotoxic, and cytotoxic effects on bacteria, fungi, and mammalian cells (9, 11, 31) . Most importantly, results of experiments designed to detect a thionin-specific protein receptor on the erythrocytes have all been negative (49). The molecular details by which G i3 activation by STb occurred from toxin binding to the plasma membrane to initiate the signal transduction cascade are unknown. However, since the amphipathic N-terminal helix of STb has a strong membrane association potential (43, 46) and our experimental results suggest STb interaction with plasma membrane of the intestinal epithelial cells, it is possible that bound STb penetrates the membrane bilayer or simply disrupts the bilayer sufficiently to directly activate G i3 . Several other naturally occurring and synthetic peptides and nonpeptide compounds, including the wasp venom mastoparan, neuropeptide substance P, the synthetic polyamine compound 48/80, and melittin, bind plasma membranes in both lipid bilayer disruptive and nondisruptive manners and activate pertussis toxin-sensitive G proteins (1, 50) . It is interesting that activation of G i by bound mastoparan also triggers exocytosis in mast cells, resulting in the release of histamine and 5-HT, same events which are thought to be primary to the intestinal secretory action of STb (20, 21, 39) .
